Thrombin inhibition during kidney ischemia-reperfusion reduces chronic graft inflammation and tubular atrophy

Transplantation

Volumn 90, Issue 6, 2010, Pages 612-621

  Thuillier, Raphael ^a,b   Favreau, Frederic ^a,b   Celhay, Olivier ^a   MacChi, Laurent ^c   Milin, Serge ^a   Hauet, Thierry ^a,b,d  

^a UNIVERSITÉ DE POITIERS   (France)

^b POITIERS UNIVERSITY HOSPITAL   (France)

^c ANGERS UNIVERSITY HOSPITAL   (France)

^d CEMAGREF   (France)

Author keywords

Inflammation; Ischemia reperfusion injury; Kidney; Transplantation; Tubular atrophy

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBIN; COMPLEMENTARY DNA; HEPARIN; MESSENGER RNA; THROMBIN; UNIVERSITY OF WISCONSIN SOLUTION; CREATININE; PRIMER DNA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTICOAGULANT THERAPY; ARTICLE; CHRONIC DISEASE; HISTOPATHOLOGY; IMMUNE RESPONSE; KIDNEY FUNCTION; KIDNEY ISCHEMIA; KIDNEY TRANSPLANTATION; KIDNEY TUBULE DISORDER; MALE; MORTALITY; NONHUMAN; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REPERFUSION INJURY; SURVIVAL RATE; SWINE; TREATMENT OUTCOME; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; AUTOTRANSPLANTATION; CADAVER; DONOR; GENETICS; HUMAN; INFLAMMATION; KIDNEY; KIDNEY TUBULE; METABOLISM; PATHOLOGY; PHYSIOLOGY; POSTMORTEM CHANGE; PROTEINURIA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUPPLY AND DISTRIBUTION;

ANIMALS; ANTITHROMBINS; CADAVER; CREATININE; DNA PRIMERS; HUMANS; INFLAMMATION; KIDNEY; KIDNEY TRANSPLANTATION; KIDNEY TUBULES; MALE; POSTMORTEM CHANGES; PROTEINURIA; REPERFUSION INJURY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SWINE; THROMBIN; TISSUE DONORS; TRANSPLANTATION, AUTOLOGOUS;

EID: 77957281866     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181d72117     Document Type: Article

References (46)

1. Meier-Kriesche HU, Schold JD, Srinivas TR, et al. Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant 2004; 4: 378.
2. Faure JP, Baumert H, Han Z, et al. Evidence for a protective role of trimetazidine during cold ischemia: Targeting inflammation and nephron mass. Biochem Pharmacol 2003; 66: 2241.
3. Hauet T, Goujon JM, Vandewalle A, et al. Trimetazidine reduces renal dysfunction by limiting the cold ischemia/reperfusion injury in auto-transplanted pig kidneys. J Am Soc Nephrol 2000; 11: 138.
4. Jayle C, Favreau F, Zhang K, et al. Comparison of protective effects of trimetazidine against experimental warm ischemia of different durations: early and long-term effects in a pig kidney model. Am J Physiol Renal Physiol 2007; 292: F1082.
5. Hauet T, Baumert H, Amor IB, et al. Pharmacological limitation of damage to renal medulla after cold storage and transplantation by tri-metazidine. J Pharmacol Exp Ther 2000; 292: 254.
6. Brook NR, Nicholson ML. Kidney transplantation from non heart-beating donors. Surgeon 2003; 1: 311.
7. Asher J, Wilson C, Gok M, et al. Factors predicting duration of delayed graft function in non-heart-beating donor kidney transplantation. Transplant Proc 2005; 37: 348.
8. Kootstra G. The asystolic, or non-heartbeating, donor. Transplantation 1997; 63: 917.
9. Rudich SM, Kaplan B, Magee JC, et al. Renal transplantations performed using non-heart-beating organ donors: Going back to the future? Transplantation 2002; 74: 1715.
10. Basile DP, Donohoe D, Roethe K, et al. Renal ischemic injury results in permanent damage to peritubular capillaries and influences long-term function. Am J Physiol Renal Physiol 2001; 281: F887.
11. Cicco G, Panzera PC, Catalano G, et al. Microcirculation and reperfu-sion injury in organ transplantation. Adv Exp Med Biol 2005; 566: 363.
12. Sutton TA. Alteration of microvascular permeability in acute kidney injury. Microvasc Res 2009; 77: 4.
13. Jang HR, Ko GJ, Wasowska BA, et al. The interaction between isch-emia-reperfusion and immune responses in the kidney. J Mol Med 2009; 87: 864.
14. Jang HR, Rabb H. The innate immune response in ischemic acute kidney injury. Clin Immunol 2009; 130: 41.
15. Lawson CA, Yan SD, Yan SF, et al. Monocytes and tissue factor promote thrombosis in a murine model of oxygen deprivation. J Clin Invest 1997; 99: 1729.
16. Koo DD, Welsh KI, Roake JA, et al. Ischemia/reperfusion injury in human kidney transplantation: An immunohistochemical analysis of changes after reperfusion. Am J Pathol 1998; 153: 557.
17. Cassie S, Masterson MF, Polukoshko A, et al. Ischemia/reperfusion induces the recruitment of leukocytes from whole blood under flow conditions. Free Radic Biol Med 2004; 36: 1102.
18. Mizutani A, Okajima K, Uchiba M, et al. Activated protein C reduces ischemia/reperfusion-induced renal injury in rats by inhibiting leukocyte activation. Blood 2000; 95: 3781.
19. Colognato R, Slupsky JR, Jendrach M, et al. Differential expression and regulation of protease-activated receptors in human peripheral mono-cytes and monocyte-derived antigen-presenting cells. Blood 2003; 102: 2645.
20. Giraud S, Thuillier R, Belliard A, et al. Direct thrombin inhibitor prevents delayed graft function in a porcine model of renal transplantation. Transplantation 2009; 87: 1636.
21. Grimm PC, Nickerson P, Gough J, et al. Computerized image analysis of Sirius Red-stained renal allograft biopsies as a surrogate marker to predict long-term allograft function. J Am Soc Nephrol 2003; 14: 1662.
22. Louapre P, Grongnet JF, Tanguay RM, et al. Effects of hypoxia on stress proteins in the piglet heart at birth. Cell Stress Chaperones 2005; 10: 17.
23. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402.
24. Pratt JR, Abe K, Miyazaki M, et al. In situ localization of C3 synthesis in experimental acute renal allograft rejection.Am J Pathol2000; 157: 825.
25. Chambers RC, Laurent GJ. Coagulation cascade proteases and tissue fibrosis. Biochem Soc Trans 2002; 30: 194.
26. Yan SF, Lawson CA, Stern DM, et al. Hypoxia-mediated modulation of vascular function\Implications for organ preservation and thrombo-genesis: Roger S. Mitchell lecture. Chest 1998; 114(1 suppl): 46S.
27. Nitescu N, Grimberg E, Ricksten SE, et al. Thrombin inhibition with melagatran does not attenuate renal ischaemia-reperfusion injury in rats. Nephrol Dial Transplant 2007; 22: 2149.
28. He CJ, Peraldi MN, Adida C, et al. Thrombin signal transduction mechanisms in human glomerular epithelial cells. J Cell Physiol 1992; 150: 475.
29. Kataoka H, Hamilton JR, McKemy DD, et al. Protease-activated receptors 1 and 4 mediate thrombin signaling in endothelial cells. Blood 2003; 102: 3224.
30. Gui Y, Loutzenhiser R, Hollenberg MD. Bidirectional regulation of renal hemodynamics by activation of PAR1 and PAR2 in isolated perfused rat kidney. Am J Physiol Renal Physiol 2003; 285: F95.
31. Grandaliano G, Monno R, RanieriE,etal. Regenerative and proinflam-matory effects of thrombin on human proximal tubular cells. J Am Soc Nephrol 2000; 11: 1016.
32. Hellstrom M, Phng LK, Gerhardt H. VEGF and Notch signaling: The yin and yang of angiogenic sprouting. Cell Adh Migr 2007; 1: 133.
33. Siekmann AF, Lawson ND. Notch signalling and the regulation of an-giogenesis. Cell Adh Migr 2007; 1: 104.
34. Siekmann AF, CovassinL, Lawson ND. ModulationofVEGF signalling output by the Notch pathway. Bioessays 2008; 30: 303.
35. Huang Y, Rabb H, Womer KL. Ischemia-reperfusion and immediate T cell responses. Cell Immunol 2007; 248: 4.
36. Ferenbach D, Kluth DC, Hughes J. Inflammatory cells in renal injury and repair. Semin Nephrol 2007; 27: 250.
37. Fletcher JT, Nankivell BJ, Alexander SI. Chronic allograft nephropathy. Pediatr Nephrol 2009; 24: 1465.
38. Nankivell BJ, Chapman JR. Chronic allograft nephropathy: Current concepts and future directions. Transplantation 2006; 81: 643.
39. Brown KM, Sacks SH, Sheerin NS. Mechanisms of disease: The complement system in renal injury\New ways of looking at anold foe. Nat Clin Pract Nephrol 2007; 3: 277.
40. Tang Z, Lu B, Hatch E, et al. C3a mediates epithelial-to-mesenchy-mal transition in proteinuric nephropathy. J Am Soc Nephrol 2009; 20: 593.
41. Djamali A, Reese S, Yracheta J, et al. Epithelial-to-mesenchymal transition and oxidative stress in chronic allograft nephropathy. Am J Transplant 2005; 5: 500.
42. Vongwiwatana A, Tasanarong A, Rayner DC, et al. Epithelial to mesenchymal transition during late deterioration of human kidney transplants: The role of tubular cells in fibrogenesis. Am J Transplant 2005; 5: 1367.
43. Bedi S, Vidyasagar A, Djamali A. Epithelial-to-mesenchymal transition and chronic allograft tubulointerstitial fibrosis. Transplant Rev (Orlando) 2008; 22: 1.
44. Kemper C, Chan AC, Green JM, et al. Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype. Nature 2003; 421: 388.
45. Hawlisch H, Wills-Karp M, Karp CL, et al. The anaphylatoxins bridge innate and adaptive immune responses in allergic asthma. Mol Immu-nol2004; 41: 123.
46. Heeger PS, Lalli PN, Lin F, et al. Decay-accelerating factor modulates induction of T cell immunity. J Exp Med 2005; 201: 1523.